v3.26.1
Condensed Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating Activities    
Net Income (Loss) $ 63 $ (135)
Non-cash reconciliation adjustments:    
Unrealized (gains) losses on derivative instruments (Note 2) 152 196
Depreciation, amortization and accretion (Note 16) 66 72
Nuclear decommissioning trust funds (gain) loss, net (excluding interest and fees) (Note 6) 35 23
Nuclear fuel amortization (Note 7) 24 26
Deferred income taxes 5 (70)
Stock-based compensation (Note 13) (1) 11
Other (Note 16) 4 26
Changes in assets and liabilities:    
Accounts receivable 38 23
Inventory, net 34 83
Other assets 19 22
Accounts payable and accrued liabilities (23) (60)
Accrued interest 66 36
Collateral received (posted), net (8) (67)
Other liabilities (13) (67)
Net cash provided by (used in) operating activities 461 119
Investing Activities    
Nuclear decommissioning trust funds investment purchases (Note 6) (112) (592)
Nuclear decommissioning trust funds investment sale proceeds (Note 6) 99 581
Property, plant and equipment expenditures (Note 7) (42) (18)
Nuclear fuel expenditures (Note 7) (27) (46)
Other 10 7
Net cash provided by (used in) investing activities (72) (68)
Financing Activities    
Revolving credit facility borrowings (Note 10) 500 0
Revolving credit facility repayments (Note 10) (500) 0
Share repurchases (Note 15) (100) (83)
Debt repayments (Note 10) (7) (4)
Deferred financing costs (3) (9)
Other (4) 0
Net cash provided by (used in) financing activities (114) (96)
Net increase (decrease) in cash and cash equivalents and restricted cash and cash equivalents 275 (45)
Beginning of period cash and cash equivalents and restricted cash and cash equivalents 752 365
End of period cash and cash equivalents and restricted cash and cash equivalents $ 1,027 $ 320